Article

Multi-Omics Integration of Transcriptomics and Metabolomics with Machine Learning Uncovers Novel Risk Factors for Alzheimer’s disease

2026-03-03

Abstract excerpt

<h4>Background</h4> Alzheimer’s disease (AD) is a neurodegenerative disorder marked by cognitive decline, memory impairment, and functional deterioration. Its complex pathogenesis involves factors such as amyloid plaques, tau tangles, neuroinflammation, and synaptic dysfunction, but the precise mechanisms remain unclear, hindering effective treatment. Genetic, environmental, and lifestyle factors contribute to AD...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 95ea07d9-90d3-5634-9d25-6390fedacb7f
DOI: 10.64898/2026.02.28.26347204

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Multi-Omics Integration of Transcriptomics and Metabolomics with Machine Learning Uncovers Novel Risk Factors for Alzheimer’s diseaseDOI 10.64898/2026.02.28.26347204Read

Predicting Alzheimer’s Disease with Multi-Omic Data: A Systematic ReviewSemantic proximity Read

Integrated analysis of genomics, longitudinal metabolomics, and Alzheimer’s risk factors among 1,111 cohort participantsSemantic proximity Read

Integrated analysis of genomics, longitudinal metabolomics, and Alzheimer's risk factors among 1,111 cohort participantsSemantic proximity Read

Unified epigenomic, transcriptomic, proteomic, and metabolomic taxonomy of Alzheimer’s disease progression and heterogeneitySemantic proximity Read

Integrative multi-omics approaches identify molecular pathways and improve Alzheimer’s Disease risk predictionSemantic proximity Read

Multiomics profiling of human plasma and CSF reveals ATN derived networks and highlights causal links in Alzheimer’s diseaseSemantic proximity Read

Brain cross-omics integration in Alzheimer’s diseaseSemantic proximity Read

Blood-Based RNA Biomarkers and Machine Learning Approaches for Alzheimer’s DiseaseSemantic proximity Read

Alzheimer's disease polygenic risk's association with all-cause dementia through the plasma metabolome in the UK Biobank study.Semantic proximity Read

Integrative multi-omics approaches identify molecular pathways and improve Alzheimer's disease risk prediction.Semantic proximity Read

Integrative-omics for discovery of network-level disease biomarkers: a case study in Alzheimer's disease.Semantic proximity Read

Advancements in multi-omics research to address challenges in Alzheimer’s disease: a systems biology approach utilizing molecular biomarkers and innovative strategiesSemantic proximity Read